Results
|
1.
|
|
|
2.
|
Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. [electronic resource] by
- Serfaty, Lawrence
- Forns, Xavier
- Goeser, Tobias
- Ferenci, Peter
- Nevens, Frederik
- Carosi, Giampiero
- Drenth, Joost P
- Lonjon-Domanec, Isabelle
- DeMasi, Ralph
- Picchio, Gaston
- Beumont, Maria
- Marcellin, Patrick
Producer: 20121119
In:
Gut vol. 61
Availability: No items available.
|
|
3.
|
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study. [electronic resource] by
- Robaeys, Geert
- Christensen, Stefan
- Lucidarme, Damien
- Arain, Amber
- Bruggmann, Philip
- Kunkel, Jan
- Keim, Sofia
- Jäkel, Martin
- DeMasi, Ralph
- Liu, Chris
- Lonjon-Domanec, Isabelle
- Foster, Graham R
Publication details: Infectious diseases and therapy Jun 2017
In:
Infectious diseases and therapy vol. 6
Availability: No items available.
|
|
4.
|
Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015. [electronic resource] by
- Sarrazin, Christoph
- Buggisch, Peter
- Mauss, Stefan
- Müller, Tobias
- Zimmermann, Tim
- Klinker, Hartwig
- Pathil-Warth, Anita
- Schlag, Michael
- Nalpas, Catherine
- Wegner, Sven
- Lonjon-Domanec, Isabelle
- Simon, Karl-Georg
Producer: 20190911
In:
Zeitschrift fur Gastroenterologie vol. 57
Availability: No items available.
|
|
5.
|
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications. [electronic resource] by
- Marra, Fiona
- Höner Zu Siederdissen, Christoph
- Khoo, Saye
- Back, David
- Schlag, Michael
- Ouwerkerk-Mahadevan, Sivi
- Bicer, Ceyhun
- Lonjon-Domanec, Isabelle
- Jessner, Wolfgang
- Beumont-Mauviel, Maria
- Kalmeijer, Ronald
- Cornberg, Markus
Producer: 20190624
In:
British journal of clinical pharmacology vol. 84
Availability: No items available.
|
|
6.
|
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1). [electronic resource] by
- Asselah, Tarik
- Moreno, Christophe
- Sarrazin, Christoph
- Gschwantler, Michael
- Foster, Graham R
- Craxí, Antonio
- Buggisch, Peter
- Ryan, Robert
- Lenz, Oliver
- Scott, Jane
- Van Dooren, Gino
- Lonjon-Domanec, Isabelle
- Schlag, Michael
- Buti, Maria
Producer: 20170726
In:
PloS one vol. 11
Availability: No items available.
|
|
7.
|
Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program. [electronic resource] by
- Colombo, Massimo
- Strasser, Simone
- Moreno, Christophe
- Abrao Ferreira, Paulo
- Urbanek, Petr
- Fernández, Inmaculada
- Abdurakmonov, Djamal
- Streinu-Cercel, Adrian
- Verheyen, Anke
- Iraqi, Wafae
- DeMasi, Ralph
- Hill, Andrew
- Lonjon-Domanec, Isabelle
- Wedemeyer, Heiner
Producer: 20150626
In:
Journal of hepatology vol. 61
Availability: No items available.
|
|
8.
|
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. [electronic resource] by
- Lepida, Antonia
- Colombo, Massimo
- Fernandez, Inmaculada
- Abdurakhmanov, Djamal
- Ferreira, Paulo Abrao
- Strasser, Simone I
- Urbanek, Petr
- Mangia, Alessandra
- Calleja, José L
- Iraqi, Wafae
- DeMasi, Ralph
- Lonjon-Domanec, Isabelle
- Moreno, Christophe
- Wedemeyer, Heiner
Producer: 20160530
In:
PloS one vol. 10
Availability: No items available.
|
|
9.
|
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response. [electronic resource] by
- Asselah, Tarik
- Moreno, Christophe
- Sarrazin, Christoph
- Gschwantler, Michael
- Foster, Graham R
- Craxí, Antonio
- Buggisch, Peter
- Sanai, Faisal
- Bicer, Ceyhun
- Lenz, Oliver
- Van Dooren, Gino
- Nalpas, Catherine
- Lonjon-Domanec, Isabelle
- Schlag, Michael
- Buti, Maria
Producer: 20170828
In:
PloS one vol. 12
Availability: No items available.
|
|
10.
|
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study. [electronic resource] by
- Berg, Thomas
- Andreone, Pietro
- Pol, Stanislas
- Roberts, Stuart
- Younossi, Zobair
- Diago, Moises
- Lawitz, Eric J
- Focaccia, Roberto
- Foster, Graham R
- Horban, Andrzej
- Lonjon-Domanec, Isabelle
- DeMasi, Ralph
- Picchio, Gaston
- Luo, Donghan
- De Meyer, Sandra
- Zeuzem, Stefan
Producer: 20151002
In:
Liver international : official journal of the International Association for the Study of the Liver vol. 35
Availability: No items available.
|
|
11.
|
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure. [electronic resource] by
- Foster, Graham R
- Zeuzem, Stefan
- Andreone, Pietro
- Pol, Stanislas
- Lawitz, Eric J
- Diago, Moises
- Roberts, Stuart
- Pockros, Paul J
- Younossi, Zobair
- Lonjon-Domanec, Isabelle
- De Meyer, Sandra
- Luo, Don
- George, Shelley
- Beumont, Maria
- Picchio, Gaston
Producer: 20130814
In:
Journal of hepatology vol. 58
Availability: No items available.
|
|
12.
|
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease. [electronic resource] by
- Hézode, Christophe
- Almasio, Piero L
- Bourgeois, Stefan
- Buggisch, Peter
- Brown, Ashley
- Diago, Moises
- Horsmans, Yves
- Serfaty, Lawrence
- Szalay, Ferenc
- Gaeta, Giovanni B
- Planas, Ramon
- Schlag, Michael
- Lonjon-Domanec, Isabelle
- Omoruyi, Edmund
- DeMasi, Ralph
- Zeuzem, Stefan
Producer: 20180522
In:
Liver international : official journal of the International Association for the Study of the Liver vol. 37
Availability: No items available.
|
|
13.
|
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial. [electronic resource] by
- Younossi, Zobair
- Negro, Francesco
- Serfaty, Lawrence
- Pol, Stanislas
- Diago, Moises
- Zeuzem, Stefan
- Andreone, Pietro
- Lawitz, Eric J
- Roberts, Stuart
- Focaccia, Roberto
- Foster, Graham R
- Horban, Andrzej
- Lonjon-Domanec, Isabelle
- Coate, Bruce
- DeMasi, Ralph
- Picchio, Gaston
- Witek, James
Producer: 20140128
In:
Hepatology (Baltimore, Md.) vol. 58
Availability: No items available.
|
|
14.
|
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. [electronic resource] by
- Bronowicki, Jean-Pierre
- Ouzan, Denis
- Asselah, Tarik
- Desmorat, Hervé
- Zarski, Jean-Pierre
- Foucher, Juliette
- Bourlière, Marc
- Renou, Christophe
- Tran, Albert
- Melin, Pascal
- Hézode, Christophe
- Chevalier, Michelle
- Bouvier-Alias, Magali
- Chevaliez, Stéphane
- Montestruc, François
- Lonjon-Domanec, Isabelle
- Pawlotsky, Jean-Michel
Producer: 20061204
In:
Gastroenterology vol. 131
Availability: No items available.
|